Form4.ai tracks every SEC insider trade in real time. See every TRDA insider filing with a free account — no card.
See every TRDA insider filing — free account, no card.
Free accountEntrada Therapeutics, Inc. (TRDA) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 10 sales totalling $8.7M. Most recent filing: Sept. 9, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 9, 2026 SEC filing | MPM BIOVENTURES 2018, L.P. 10% Owner Same trade as MPM BioVentures 2014, L.P. | Sold | $1,905,768 | — |
| Sep 3, 2026 SEC filing | MPM BIOVENTURES 2018, L.P. 10% Owner Same trade as MPM BioVentures 2014, L.P. | Sold | $617,379 | — |
| Sep 3, 2026 SEC filing | Doshi Dipal CEO | Tax withholding | $62,323 | — |
Create a free account to see all 14 TRDA filings from the last 90 days. No card needed.
Create free accountWant TRDA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.